Plavsic Mark 4
4 · FATE THERAPEUTICS INC · Filed Jan 27, 2022
Insider Transaction Report
Form 4
Plavsic Mark
Chief Technical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-25+53,058→ 53,058 totalExercise: $39.87Exp: 2032-01-24→ Common Stock (53,058 underlying) - Award
Common Stock
2022-01-25+33,302→ 130,842 total
Footnotes (2)
- [F1]Award of restricted stock units that vest with respect to 1/4th of the underlying shares on each of January 8, 2023, January 8, 2024, January 8, 2025 and January 8, 2026, subject to the Reporting Person's continued service with the Issuer as of each such date.
- [F2]The shares subject to this option vest in 48 equal month installments beginning on February 1, 2022 such that this option will be fully exercisable on January 1, 2026, subject to the Reporting Person's continued service with the Issuer as of each such date.